港股创新药 (931787.csi)编制方案单张 | ( 市盈率 38.52 | 市净率 4.30 | 股息率 0.70% )·市值加权 | 发布时间2018-08-14样本数37调样频率半年类型主题热点收盘点位1,556.91点位涨跌幅-1.48%成交金额306.71亿港币市值2.53万亿港币A股市值1.96万亿港币前十大权重70.51%发布以来年化涨跌幅9.48%有数据以来全收益年化涨跌幅7.28% | |
| 中证香港创新药指数在香港市场中选取不超过50家主营业务涉及创新药研发的上市公司证券作为指数样本，以反映香港市场创新药主题上市公司证券的整体表现。®基础数据源自中证指数公司。指数估值数据计算说明文档指数财务数据计算说明文档 | |||||
| 备注 (16) | 双击编辑备注 | ||||
港股创新药(931787) - 历史市销率(平均值)及分位点走势图
最后更新于：2025-08-26
| 日期 | 收盘点位 | 市销率 | 分位点 | 20%分位点 | 50%分位点 | 80%分位点 |
|---|---|---|---|---|---|---|
| 2025-08-26 | 1,556.91 | 15.61 | 87.38% | 5.94 | 8.91 | 13.92 |
| 2025-08-25 | 1,580.35 | 15.68 | 87.65% | 5.94 | 8.91 | 13.92 |
| 2025-08-22 | 1,575.87 | 15.80 | 87.69% | 5.94 | 8.98 | 13.95 |
| 2025-08-21 | 1,546.33 | 16.20 | 88.90% | 5.94 | 8.98 | 13.95 |
| 2025-08-20 | 1,507.70 | 16.41 | 89.57% | 5.94 | 8.91 | 13.92 |
| 2025-08-19 | 1,548.85 | 17.21 | 90.77% | 5.94 | 8.91 | 13.92 |
| 2025-08-18 | 1,578.60 | 17.08 | 90.37% | 5.94 | 8.91 | 13.92 |
| 2025-08-15 | 1,557.23 | 16.73 | 89.72% | 5.94 | 8.98 | 13.95 |
| 2025-08-14 | 1,526.99 | 16.33 | 89.04% | 5.94 | 8.98 | 13.95 |
| 2025-08-13 | 1,510.37 | 16.08 | 88.21% | 5.94 | 8.91 | 13.92 |
| 2025-08-12 | 1,445.37 | 15.39 | 86.84% | 5.94 | 8.91 | 13.92 |
| 2025-08-11 | 1,465.95 | 15.70 | 87.52% | 5.94 | 8.91 | 13.92 |
| 2025-08-08 | 1,454.72 | 15.57 | 86.87% | 5.94 | 8.98 | 13.95 |
| 2025-08-07 | 1,465.14 | 15.56 | 86.74% | 5.94 | 8.98 | 13.95 |
| 2025-08-06 | 1,524.12 | 16.19 | 88.21% | 5.94 | 8.91 | 13.92 |
| 2025-08-05 | 1,522.61 | 14.43 | 82.90% | 5.94 | 8.91 | 13.92 |
| 2025-08-04 | 1,454.23 | 13.37 | 78.29% | 5.94 | 8.91 | 13.92 |
| 2025-08-01 | 1,451.03 | 13.12 | 77.40% | 5.94 | 8.98 | 14.00 |
| 2025-07-31 | 1,488.68 | 13.50 | 78.21% | 5.94 | 8.98 | 14.00 |
| 2025-07-30 | 1,508.62 | 15.00 | 84.55% | 5.94 | 8.91 | 14.00 |
| 2025-07-29 | 1,539.41 | 14.20 | 80.87% | 5.93 | 8.91 | 14.00 |
| 2025-07-28 | 1,472.41 | 13.73 | 79.38% | 5.93 | 8.91 | 14.00 |
| 2025-07-25 | 1,417.80 | 13.10 | 77.00% | 5.94 | 8.98 | 14.12 |
| 2025-07-24 | 1,426.33 | 13.39 | 77.81% | 5.94 | 8.98 | 14.16 |
